USA - NYSEARCA:BHB - US0668491006 - Common Stock
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 149.54M | 150.73M | 152.75M | 148.33M | 137.90M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 116.93M | 113.84M | 117.67M | 113.68M | 95.60M | |||
| Non Interest Income | 32.61M | 36.89M | 35.07M | 34.65M | 42.30M | |||
| Loan Loss Provision | 2.36M | 2.13M | 2.91M | 2.90M | -1.30M | |||
| Net Interest Income after Provision | 114.57M | 111.71M | 114.77M | 110.78M | 96.90M | |||
| Non Interest Expense | -99.85M | -95.99M | -92.72M | -90.58M | -90.50M | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 47.33M | 52.61M | 57.12M | 54.84M | 48.60M | |||
| Income Tax | 7.84M | 9.07M | 12.27M | 11.29M | 9.30M | |||
| Net Income | 39.49M | 43.54M | 44.85M | 43.56M | 39.30M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.5709999999999997 | 2.844 | 2.9518 | 2.8823 | 2.61 | |||
| Non GAAP EPS | 2.58 | 2.85 | 2.93 | 2.91 | null | |||
| Statistics | ||||||||
| Profit Margin | 26.41% | 28.89% | 29.36% | 29.37% | 28.50% | |||
All data in USD